#4554
Base on deep learning-integrated multimodal diagnostic framework for enhanced early detection of neuroendocrine tumours
Introduction:
Neuroendocrine tumours (NETs) are a heterogeneous group of malignant neoplasms originating from neuroendocrine cells, commonly found in the digestive system, lungs, pancreas, and other organs. Due to their diverse clinical presentations and overlap with common diseases, the early diagnosis of NETs is challenging, often leading to misdiagnosis or delayed diagnosis at advanced stages.
Conference:
Presenting Author:
Authors:
Ding Z,
Li H,
Tang Z,
Chen Y,
Li H,
Keywords:
Neuroendocrine Tumour,
Early Disease Screening,
Multimodal Medical Data Analysis,
#4512
A deep learning-integrated multimodal diagnostic framework for enhanced early detection of neuroendocrine tumours
Introduction:
Neuroendocrine tumours (NETs) are a heterogeneous group of malignant neoplasms originating from neuroendocrine cells, commonly found in the digestive system, lungs, pancreas, and other organs. Due to their diverse clinical presentations and overlap with common diseases, the early diagnosis of NETs is challenging, often leading to misdiagnosis or delayed diagnosis at advanced stages. While current imaging techniques and biomarkers are useful in certain cases, their diagnostic sensitivity and specificity remain limited when used in isolation.
Conference:
Presenting Author:
Authors:
Ding Z,
Li H,
Tang Z,
Chen Y,
Li H,
Keywords:
Neuroendocrine Tumour,
Multimodal Diagnostic algorithm,
Deep Learning,
Early Disease Screening,
#4492
Utility of NETest 2.0 as a biomarker for neuroendocrine tumours: The Swiss experience – Real-world data
Introduction:
The NETest 2.0 is a PCR assay of circulating mRNA, scored 0-100. It has been developed as a biomarker to diagnose neuroendocrine neoplasia (NEN) and to provide tumour prognostic information.
Conference:
Presenting Author:
Chirindel A
Authors:
Chirindel A,
Wild D,
Voegeli M,
de Dosso S,
Siebenhüner A,
Keywords:
NETest,
tumour biomarker,
NEN,
disease presence,
disease progression,
#221
Diagnostic Algorithm of Pancreatic Neuroendocrine Tumors
Introduction:
Diagnostics of pNETs is associated with certain problems due to a variety of clinical features, including a rather small size of primaries and, quite often, multiple lesions.
Conference:
8th Annual ENETSConcerence (2011)
Presenting Author:
Authors:
Egorov A,
Kondrashin S,
Musaev G,
Vasiliev I,
Anisimova O,
Keywords:
pancreatic neuroendocrine tumor,
diagnostic algorithm,
arterial stimulated blood sampling,
